Expertise in
9
conditions

Dr. Patricia A. Defusco

Internal Medicine
Avon Helen & Harry Gray Cancer Center-Radiation Oncology
80 Fisher Dr, 
Avon, CT 
Offers Telehealth
Expertise in
9
conditions
Avon Helen & Harry Gray Cancer Center-Radiation Oncology
80 Fisher Dr, 
Avon, CT 

Overview

Patricia Defusco is a primary care provider, practicing in Internal Medicine in Avon, Connecticut.

Dr. Defusco is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and BRCA Positive Breast Cancer.

She is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 5 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in CT

Hospital Affiliations

Hartford Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Avon Helen & Harry Gray Cancer Center-Radiation Oncology
80 Fisher Dr, Avon, CT 06001
Other Locations
Hartford Healthcare Cancer Institute
376 Tolland Tpke, Manchester, CT 06042

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: May 29, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Enrollment Status: Completed
Publish Date: February 19, 2026
Intervention Type: Drug
Study Drugs: Trastuzumab, Paclitaxel, Trastuzumab emtansine
Study Phase: Phase 2
A Multicenter, Open-Label, Randomized-Controlled Study of Abemaciclib, a CDK4 and 6 Inhibitor, in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer With Visceral Metastases
A Multicenter, Open-Label, Randomized-Controlled Study of Abemaciclib, a CDK4 and 6 Inhibitor, in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer With Visceral Metastases
Enrollment Status: Terminated
Publish Date: August 24, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

11 Total Publications

Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy.
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy.
Journal: JACC. CardioOncology
Published: January 24, 2025
Similar Doctors
Expertise in
24
conditions
Dr. Pramod K. Mistry
Internal Medicine
Expertise in
24
conditions
Dr. Pramod K. Mistry
Internal Medicine

Radiology And Biomedical Imaging-New Haven-Yale Physicians Building

800 Howard Ave, 
New Haven, CT 
 (35.9 miles away)
203-785-7352
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pramod Mistry is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. Dr. Mistry is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Gaucher Disease Type 1, Gaucher Disease, Gaucher Disease Type 3, Splenomegaly, and Splenectomy.

Expertise in
26
conditions
Dr. Harlan M. Krumholz
Internal Medicine
Expertise in
26
conditions
Dr. Harlan M. Krumholz
Internal Medicine

Office

1 Church St Ste 200, 
New Haven, CT 
 (35.6 miles away)
203-764-5885
Languages Spoken:
English
See accepted insurances

Harlan Krumholz is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. Dr. Krumholz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Heart Attack, Heart Failure, Pulmonary Embolism, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Expertise in
16
conditions
Dr. Mario Strazzabosco
Internal Medicine
Expertise in
16
conditions
Dr. Mario Strazzabosco
Internal Medicine

Yale New Haven Hospital

20 York St, 
New Haven, CT 
 (35.8 miles away)
203-737-6060
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mario Strazzabosco is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. He has been practicing medicine for over 44 years. Dr. Strazzabosco is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Congenital Hepatic Fibrosis, Caroli Disease, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy.

Frequently Asked Questions about Dr. Patricia A. Defusco

How do I make an appointment with Dr. Patricia A. Defusco?

You can book an appointment with Dr. Patricia A. Defusco by calling their office at 860-674-0088. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Patricia A. Defusco a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Patricia A. Defusco is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Patricia A. Defusco specialize in?

While Dr. Patricia A. Defusco is a Internal Medicine, they have specific expertise in Breast Cancer, HER-2 Positive Breast Cancer, and Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Patricia A. Defusco participate in research or clinical trials?

Yes. Dr. Patricia A. Defusco has published 11 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Patricia A. Defusco's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Patricia A. Defusco accept my insurance?

Dr. Patricia A. Defusco accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 860-674-0088 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Defusco's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile